http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006023397-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c78dbed06cf729a4fd116d155e8aa1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4655e145424240e669df3c07a6f863 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_947d6cc9fd28f2fa1f9c00c0246f15ea |
| publicationDate | 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006023397-A2 |
| titleOfInvention | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| abstract | A method and medicament for anticoagulating a patient with a sulfated polysaccharide mixture that demonstrates enhanced anti-inflammatory activity compared to anticoagulation with unfractionated heparin comprising various combinations of fully anticoagulant unfractionated heparin with 2-O desulfated heparin demonstrating reduced anticoagulant activity but enhanced antiinflammatory actions. The medicament preferably is administered intravenously, by aerosolization or orally. Preferably, the 2-O desulfated heparin medicament includes a physiologically acceptable carrier which may be selected from the group consisting of physiologically buffered saline, normal saline and distilled water. Additionally provided is a method of synthesizing 2-O desulfated heparin in commercially practical quantities for the formulation of an anticoagulant 2-O desulfated heparin and heparin mixture. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556230-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229664-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201586-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052346-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018167-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800816-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873720-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001613-B2 |
| priorityDate | 2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 697.